EP3180025
ANTI-VEGFR2 ANTIBODY THERAPY FOR HEPATOCELLULAR CARCINOMA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.8.2015EP published:
26.2.2020EP application number:
15754347.1
EPO information:
European Patent Register
Max expiry date:
10.8.2035
Title:
ANTI-VEGFR2 ANTIBODY THERAPY FOR HEPATOCELLULAR CARCINOMA
Timeline
Today
11.8.2015EP application
26.2.2020EP Publication
Owner
Name:
Imclone, LLCAddress:
Eli Lilly and Company Lilly Corporate Center, Indianapolis, Indiana 46285, US
Inventor
Name:
ABADA, Paolo BenjaminAddress:
Indianapolis, Indiana 46206-6288, US
Name:
CHANG, Shao-ChunAddress:
Indianapolis, Indiana 46206-6288, US
Name:
HSU, YanzhiAddress:
Indianapolis, Indiana 46206-6288, US
Name:
YANG, LingAddress:
Indianapolis, Indiana 46206-6288, US
Priority
Number:
201462037848 PDate:
15.8.2014Country:
US
Classification
Categories:
A61K 39/395, A61P 35/00, G01N 33/574, C07K 16/28, C07K 16/30